Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Rosuvastatin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/20/2021 2 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Sarilumab  Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/29/2021 4 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Ambroxol Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021 2 0
Excel (.xslx) CSV (.csv)